Glucagon Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Glucagon Market
The global glucagon market size was valued at USD 278.5 million in 2022 and is projected to grow from USD 297.8 million in 2023 to USD 470.8 million by 2030, exhibiting a CAGR of 6.8% during the forecast period of 2023-2030.
The COVID-19 pandemic brought about disruptions within the glucagon marketplace because of delivery chain interruptions and behind-schedule clinical remedies. However, the consistent demand for glucagon in coping with intense hypoglycemia and diabetes-related emergencies helped preserve market stability, impeding the glucagon market growth.
The riding factors for the glucagon market include the rising prevalence of diabetes, increasing cognizance of approximate hypoglycemia management, and improvements in glucagon transport systems. Additionally, developing healthcare infrastructure and developing modern glucagon products, such as nasal sprays and auto-injectors, contribute to marketplace growth.
Combination products are becoming increasingly popular in the glucagon marketplace, integrating glucagon pens with other diabetes control gadgets, including continuous glucose video display units (CGMs) and insulin pumps. This integration streamlines diabetes control by providing a more complete and coordinated technique, expanding the glucagon market share globally. By combining these gadgets, patients can better track their blood sugar degrees, alter insulin doses, and administer glucagon as wanted, improving universal glycemic management and decreasing the threat of hypoglycemia.
Comprehensive Analysis of Glucagon Market
The glucagon market is segmented using courses of administration, software, and distribution channels. In 2022, the inhalation section led because of its ease of use and no need for preparation, using its popularity amongst patients. The injectable phase additionally noticed a remarkable boom due to conventional emergency kits and new liquid-strong formulations. By application, the hypoglycemia section ruled, fueled using the rising diabetic population and more than a few remedy options. Regarding distribution channels, drug stores and retail pharmacies held the largest share. In contrast, online pharmacies are expected to grow hastily due to growing affected personal preferences for online purchases.
The North America region led the glucagon market by benefitting a size of USD 239.2 million in 2022 due to a focal point on strengthening their distribution networks and prioritizing regulatory approvals.
The main players in the glucagon market significantly influence its increased trajectory and set enterprise requirements. These key gamers, which include Novo Nordisk A/S (Denmark), Fresenius SE & Co. KGaA (Germany), Amphastar Pharmaceuticals, Inc. (U.S.), Xeris Biopharma Holdings, Inc. (U.S.), ILS Inc. (Japan), United Biotech (P) Limited (India), Zealand Pharma A/S (Denmark), and Taj Pharmaceuticals Limited (India), make contributions to an aggressive panorama, riding innovation and advancing the market.
In June 2023, Amphastar Pharmaceuticals, Inc. Expanded its product portfolio by acquiring BAQSIMI, a medical emergency treatment for intense hypoglycemia, from Eli Lilly and Company.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2017-2030
Base Year 2022
Estimated Year 2023
Forecast Period 2023-2030
Historical Period 2017-2021
Growth Rate CAGR of 6.8% from 2023 to 2030
Unit Value (USD Million), Volume (1,000 Units)
Segmentation By Route of Administration
Injectable
Inhalation
By Application
Hypoglycemia
Diagnostic Aid
By Distribution Channel
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
By Region
North America (By Route of Administration, Application, Distribution Channel, and Country)
U.S.
Canada
Europe (By Route of Administration, Application, Distribution Channel, and Country/ Sub-Region)
U.K.
Germany
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Route of Administration, Application, Distribution Channel, and Country/ Sub-Region)
Japan
China
India
Australia
Southeast Asia
Rest of Asia Pacific
Latin America (By Route of Administration, Application, Distribution Channel, and Country/ Sub-Region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (By Route of Administration, Application, Distribution Channel, and Country/ Sub-Region)
GCC
South Africa
Rest of the Middle East & Africa
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Hypoglycemia, Key Countries/Regions, 2022
- 4.2. Pipeline Analysis, By Key Players
- 4.3. Key Industry Developments, By Key Players
- 4.4. Impact of COVID-19 on the Market
- 5. Global Glucagon Market Analysis, Insights and Forecast, 2017-2030
- 5.1. Market Analysis, Insights and Forecast – By Route of Administration
- 5.1.1. Injectable
- 5.1.2. Inhalation
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Hypoglycemia
- 5.2.2. Diagnostic Aid
- 5.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.3.1. Hospital Pharmacies
- 5.3.2. Drug Stores & Retail Pharmacies
- 5.3.3. Online Pharmacies
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Glucagon Market Analysis, Insights and Forecast, 2017-2030
- 6.1. Market Analysis, Insights and Forecast – By Route of Administration
- 6.1.1. Injectable
- 6.1.2. Inhalation
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. Hypoglycemia
- 6.2.2. Diagnostic Aid
- 6.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.3.1. Hospital Pharmacies
- 6.3.2. Drug Stores & Retail Pharmacies
- 6.3.3. Online Pharmacies
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Glucagon Market Analysis, Insights and Forecast, 2017-2030
- 7.1. Market Analysis, Insights and Forecast – By Route of Administration
- 7.1.1. Injectable
- 7.1.2. Inhalation
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. Hypoglycemia
- 7.2.2. Diagnostic Aid
- 7.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.3.1. Hospital Pharmacies
- 7.3.2. Drug Stores & Retail Pharmacies
- 7.3.3. Online Pharmacies
- 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia Pacific Glucagon Market Analysis, Insights and Forecast, 2017-2030
- 8.1. Market Analysis, Insights and Forecast – By Route of Administration
- 8.1.1. Injectable
- 8.1.2. Inhalation
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. Hypoglycemia
- 8.2.2. Diagnostic Aid
- 8.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.3.1. Hospital Pharmacies
- 8.3.2. Drug Stores & Retail Pharmacies
- 8.3.3. Online Pharmacies
- 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Latin America Glucagon Market Analysis, Insights and Forecast, 2017-2030
- 9.1. Market Analysis, Insights and Forecast – By Route of Administration
- 9.1.1. Injectable
- 9.1.2. Inhalation
- 9.2. Market Analysis, Insights and Forecast – By Application
- 9.2.1. Hypoglycemia
- 9.2.2. Diagnostic Aid
- 9.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.3.1. Hospital Pharmacies
- 9.3.2. Drug Stores & Retail Pharmacies
- 9.3.3. Online Pharmacies
- 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
- 10. Middle East & Africa Glucagon Market Analysis, Insights and Forecast, 2017-2030
- 10.1. Market Analysis, Insights and Forecast – By Route of Administration
- 10.1.1. Injectable
- 10.1.2. Inhalation
- 10.2. Market Analysis, Insights and Forecast – By Application
- 10.2.1. Hypoglycemia
- 10.2.2. Diagnostic Aid
- 10.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 10.3.1. Hospital Pharmacies
- 10.3.2. Drug Stores & Retail Pharmacies
- 10.3.3. Online Pharmacies
- 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2022)
- 11.2. Company Profiles
- 11.2.1. Novo Nordisk
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Fresenius Kabi
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Amphastar Pharmaceuticals, Inc.
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Xeris Biopharma Holdings, Inc.
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. ILS.Inc
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. United Biotech Pvt. Ltd.
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Zealand Pharma A/S
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Taj Pharmaceuticals Limited
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook